imlifidase

Zgjim Osmani1, Aiko P J de Vries2,3, Arjan Albersen1

  • 1Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Transfusion
|October 11, 2025
PubMed
概括

对于脏移植的伊姆利菲达斯治疗可能会导致输血对抗体查中的假阴性结果. 这种干扰可能导致不兼容的输血和溶血反应,因此需要对治疗患者的结果进行仔细解释.